levodopa/carbidopa/entacapone orion
orion corporation - levodopa, carbidopa, entakapon - parkinsons sygdom - nervesystem - levodopa/carbidopa/entacapone orion er indiceret til behandling af voksne patienter med parkinsons sygdom og slutningen af dosis motor udsving ikke stabiliseret på levodopa / dopa-decarboxylase (ddc)-inhibitor behandling.
carbidopa/levodopa "2care4" 25+100 mg tabletter
2care4 aps - carbidopamonohydrat, levodopa - tabletter - 25+100 mg
carbidopa/levodopa "orion" 12,5+50 mg tabletter
orion corporation - carbidopamonohydrat, levodopa - tabletter - 12,5+50 mg
carbidopa/levodopa "fair-med" 12,5+50 mg tabletter
fair-med healthcare gmbh - carbidopa, levodopa - tabletter - 12,5+50 mg
carbidopa/levodopa "fair-med" 25+100 mg tabletter
fair-med healthcare gmbh - carbidopa, levodopa - tabletter - 25+100 mg
carbidopa/levodopa "nordic prime" 25+100 mg tabletter
nordic prime aps - carbidopa, levodopa - tabletter - 25+100 mg
carbidopa/levodopa "orion" 25+100 mg tabletter
orion corporation - carbidopamonohydrat, levodopa - tabletter - 25+100 mg
corbilta (previously levodopa/carbidopa/entacapone sandoz)
orion corporation - levodopa, carbidopa, entakapon - parkinsons sygdom - anti-parkinson-lægemidler - corbilta er indiceret til behandling af voksne patienter med parkinsons sygdom og motoriske udsving i slutningen af dosis, der ikke stabiliseres ved behandling med levodopa / dopa decarboxylase (ddc).
carbidopa/levodopa "fair-med" 25+100 mg tabletter
orifarm a/s - carbidopa, levodopa - tabletter - 25+100 mg
levodopa/carbidopa/entacapone "rivopharm" 100+25+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 100+25+200 mg